92
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Synthesis and Identification of a Novel Peptide, Ac-SDK (Biotin) Proline, That Can Elicit Anti-Fibrosis Effects in Rats Suffering from Silicosis

, , , , , , , , & show all
Pages 4315-4326 | Published online: 19 Oct 2020

References

  • FranklinBS, ManganMS, LatzE. Crystal formation in inflammation. Annu Rev Immunol. 2016;34:173–202. doi:10.1146/annurev-immunol-041015-05553926772211
  • LeungCC, YuIT, ChenW. Silicosis. Lancet. 2012;379(9830):2008–2018. doi:10.1016/S0140-6736(12)60235-922534002
  • ThierryJ, GrillonC, GaudronS, PotierP, RichesA, Wdzieczak-BakalaJ. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation. J Pept Sci. 2001;7(5):284–293. doi:10.1002/psc.32211428549
  • CavasinMA, LiaoTD, YangXP, YangJJ, CarreteroOA. Decreased endogenous levels of Ac-SDKP promote organ fibrosis. Hypertension. 2007;50(1):130–136.17470726
  • SharmaUC, SonkawadeSD, SpernyakJA, et al. A small peptide Ac-SDKP inhibits radiation-induced cardiomyopathy. Circ Heart Fail. 2018;11(8):e004867. doi:10.1161/CIRCHEARTFAILURE.117.00486730354563
  • RomeroCA, KumarN, NakagawaP, et al. Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney. Am J Physiol Renal Physiol. 2019;316(1):F195–F203. doi:10.1152/ajprenal.00270.201830403163
  • ZhangB, XuH, ZhangY, et al. Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway. Toxicol Lett. 2019;313:30–41. doi:10.1016/j.toxlet.2019.05.02331181250
  • PejmanS, KamareheiM, RiaziG, PooyanS, BalalaieS. Ac-SDKP ameliorates the progression of experimental autoimmune encephalomyelitis via inhibition of ER stress and oxidative stress in the hippocampus of C57BL/6 mice. Brain Res Bull. 2020;154:21–31. doi:10.1016/j.brainresbull.2019.09.01431589901
  • NtsekheM, MatthewsK, WolskeJ, et al. Scientific letter: ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction. Heart. 2012;98(17):1326–1328. doi:10.1136/heartjnl-2012-302196
  • YangF, YangXP, LiuYH, et al. Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension. 2004;43(2):229–236. doi:10.1161/01.HYP.0000107777.91185.8914691195
  • ZhangL, XuLM, ChenYW, et al. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats. World J Gastroenterol. 2012;18(37):5283–5288.23066324
  • SrivastavaSP, ShiS, KanasakiM, et al. Effect of antifibrotic MicroRNAs crosstalk on the action of N-acetyl-seryl-aspartyl-lysyl-proline in diabetes-related kidney fibrosis. Sci Rep. 2016;6:29884. doi:10.1038/srep2988427425816
  • WorouME, LiaoTD, D’AmbrosioM, et al. Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats. Hypertension. 2015;66(4):816–822. doi:10.1161/HYPERTENSIONAHA.115.0597026324505
  • ZhangL, XuD, LiQ, et al. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates silicotic fibrosis by suppressing apoptosis of alveolar type II epithelial cells via mediation of endoplasmic reticulum stress. Toxicol Appl Pharmacol. 2018;350:1–10. doi:10.1016/j.taap.2018.04.02529684394
  • XuH, YangF, SunY, et al. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis. PLoS One. 2012;7(7):e40301. doi:10.1371/journal.pone.004030122802960
  • DengH, YangF, XuH, et al. Ac-SDKP suppresses epithelial-mesenchymal transition in A549 cells via HSP27 signaling. Exp Mol Pathol. 2014;97(1):176–183. doi:10.1016/j.yexmp.2014.07.00324998956
  • DengH, XuH, ZhangX, et al. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-beta1/ROCK1 pathway in silicosis in rat. Toxicol Appl Pharmacol. 2016;294:1–10. doi:10.1016/j.taap.2016.01.01026785300
  • MaX, YuanY, ZhangZ, ZhangY, LiM. An analog of Ac-SDKP improves heart functions after myocardial infarction by suppressing alternative activation (M2) of macrophages. Int J Cardiol. 2014;175(2):376–378. doi:10.1016/j.ijcard.2014.05.01624874903
  • MasuyerG, DouglasRG, SturrockED, AcharyaKR. Structural basis of Ac-SDKP hydrolysis by angiotensin-I converting enzyme. Sci Rep. 2015;5:13742. doi:10.1038/srep1374226403559
  • FujiiS, MoriS, KagechikaH, Mendoza ParraMA, GronemeyerH. Development of biotin-retinoid conjugates as chemical probes for analysis of retinoid function. Bioorg Med Chem Lett. 2018;28(14):2442–2445. doi:10.1016/j.bmcl.2018.06.01129908657
  • LinWZ, ChenYH, LiangCK, LiuCC, HouSY. A competitive immunoassay for biotin detection using magnetic beads and gold nanoparticle probes. Food Chem. 2019;271:440–444. doi:10.1016/j.foodchem.2018.07.15230236699
  • Ohmuro-MatsuyamaY, YamashitaT, GomiK, YamajiH, UedaH. Evaluation of protein-ligand interactions using the luminescent interaction assay FlimPIA with streptavidin-biotin linkage. Anal Biochem. 2018;563:61–66. doi:10.1016/j.ab.2018.10.01030316750
  • KojimaN, SudaT, KurinomaruT, KuritaR. Immobilization of DNA with nitrogen mustard-biotin conjugate for global epigenetic analysis. Anal Chim Acta. 2018;1043:107–114. doi:10.1016/j.aca.2018.09.00830392657
  • QianW, CaiX, QianQ Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition. Aging (Albany NY). 2020;12(5):4322–4336. doi:10.18632/aging.10288232139663
  • ZuoH, Trombetta-LimaM, HeijinkIH, et al. A-kinase anchoring proteins diminish TGF-beta1/cigarette smoke-induced epithelial-to-mesenchymal transition. Cells. 2020;9(2):356. doi:10.3390/cells9020356
  • ZhangK, FanC, CaiD, et al. Contribution of TGF-beta-mediated NLRP3-HMGB1 activation to tubulointerstitial fibrosis in rat with angiotensin ii-induced chronic kidney disease. Front Cell Dev Biol. 2020;8:1. doi:10.3389/fcell.2020.0000132117956
  • SongL, ChenTY, ZhaoXJ, et al. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-beta1/Smads signalling. Br J Pharmacol. 2019;176(11):1619–1634. doi:10.1111/bph.1457330632134
  • JungJ, LeeYJ, ChoiYH, ParkEM, KimHS, KangJL. Gas6 prevents epithelial-mesenchymal transition in alveolar epithelial cells via production of PGE2, PGD2 and their receptors. Cells. 2019;8(7):643. doi:10.3390/cells8070643
  • LiuP, ZhangB, ChenZ, et al. m(6)A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway. Aging (Albany NY). 2020;12(6):5280–5299. doi:10.18632/aging.10295032203053
  • ShifengL, HongX, XueY, et al. Ac-SDKP increases alpha-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-beta1 and silica. Toxicol Appl Pharmacol. 2019;369:17–29. doi:10.1016/j.taap.2019.02.01530826375
  • KumarN, NakagawaP, JanicB, et al. The anti-inflammatory peptide Ac-SDKP is released from thymosin-beta4 by renal meprin-alpha and prolyl oligopeptidase. Am J Physiol Renal Physiol. 2016;310(10):F1026–F1034. doi:10.1152/ajprenal.00562.201526962108
  • ChenY, XuD, YaoJ, et al. Inhibition of miR-155-5p exerts anti-fibrotic effects in silicotic mice by regulating meprin alpha. Mol Ther Nucleic Acids. 2020;19:350–360. doi:10.1016/j.omtn.2019.11.01831877411
  • ZhuoJL, CarreteroOA, PengH, et al. Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2007;292(2):H984–H993. doi:10.1152/ajpheart.00776.200617028162
  • ZhangX, ZhouJ, ZhuY, et al. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis. IUBMB Life. 2019;71(9):1302–1312. doi:10.1002/iub.203730900390